London & Capital Glb Eq Opps I USD Acc

Performance History30/06/2024
Growth of 1,000 (EUR)
London & Capital Glb Eq Opps I USD Acc
Fund---28.110.2
+/-Cat---9.3-3.4
+/-Idx---2.9-8.4
 
Key Stats
NAV
25/07/2024
 USD 134.72
Day Change -1.43%
Morningstar Category™ Global Large-Cap Growth Equity
ISIN IE000RA27EK8
Fund Size (Mil)
25/07/2024
 USD 48.24
Share Class Size (Mil)
25/07/2024
 USD 1.78
Max Initial Charge -
Ongoing Charge
19/02/2024
  1.44%
Investment Objective: London & Capital Glb Eq Opps I USD Acc
To seek to provide long-term capital growth through investments in global equities.
Returns
Trailing Returns (EUR)25/07/2024
YTD4.41
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
-
-
Inception Date
30/11/2022
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
-Morningstar Gbl Growth TME NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNo
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  London & Capital Glb Eq Opps I USD Acc30/06/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks99.620.0099.62
Bonds0.000.000.00
Cash0.690.310.38
Other0.000.000.00
Top 5 Regions%
United States85.13
Eurozone6.66
Asia - Developed4.72
Europe - ex Euro3.49
Canada0.00
Top 5 Sectors%
Technology36.23
Healthcare23.21
Financial Services19.44
Communication Services8.68
Consumer Cyclical6.32
Top 5 HoldingsSector%
Alphabet Inc Class CCommunication ServicesCommunication Services8.64
Microsoft CorpTechnologyTechnology7.92
Cadence Design Systems IncTechnologyTechnology7.57
Intuitive Surgical IncHealthcareHealthcare6.59
Align Technology IncHealthcareHealthcare5.50
London & Capital Glb Eq Opps I USD Acc

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures